Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.65% to 7,377.90.
Resmed CDI (ASX:RMD) shares and the Monash IVF Group Ltd (ASX:MVF) share price look very tempting at these prices, writes Seneca’s Luke Laretive.
Monash IVF (ASX:MVF) shares are down 1% despite announcing that it is seeing a recovery in the IVF market.
Monash IVF Group Ltd (ASX:MVF) released its FY19 report this morning, and shareholders may be in for more pain after the announcement last week that sent the share price down 26%.
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) rose by 0.45% on Wednesday.
The Monash IVF Group Ltd (ASX:MVF) share price jumped nearly 5% yesterday after announcing the acquisition of another fertility clinic.
Monash IVF Group Ltd (ASX:MVF) has announced an acquisition to the market to grow its profit.
The Monash IVF Group Ltd (ASX:MVF) share price could fall after NSW Premier Gladys Berejiklian announced a $42 million package for IVF treatment.
Monash IVF Group Ltd (ASX:MVF) today released its half-year results to the market reporting its net profit after tax (NPAT) slumped 19.8% to $9.67 million.
